Miracell, a Korean biotech company, unveiled its plans to expand into the stem cell biohealth market in Dubai of the United Arab Emirates on Wednesday, as part of efforts to strengthen its presence in the Gulf Cooperation Council region.

Dubai has become a key center for the medical and biohealth industries in the Middle East, driven by both rising demand for healthcare services and interest in technological innovation.

Miracell aims to develop stem cell therapies for various diseases, providing patients with alternative treatment options in the field of regenerative medicine.

The company is also seeking to collaborate with local medical institutions and research organizations. These partnerships are expected to support joint research, enable technology transfer and lower market entry barriers.

In addition, Miracell intends to hold seminars and workshops aimed at health care professionals and the public to increase understanding of stem cell technologies.

The company’s move into the Dubai market reflects its broader strategy to expand internationally while contributing to the development of regenerative medicine in the GCC region. By entering the Middle East, Miracell aims to build credibility and explore new avenues for growth.

View original article: https://www.koreaherald.com/article/10477784